欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1138/001
药品名称Lacosamide hameln 10 mg/ml
活性成分
    • LACOSAMIDE 10.0 mg/ml
剂型Solution for infusion
上市许可持有人Hameln Pharma GmbH Inselstrasse 1, Innenstadt, Hameln Lower Saxony 31787 Germany
参考成员国 - 产品名称Finland (FI)
Lacosamide hameln
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
      Lacosamide hameln 10 mg/ml oplossing voor infusie
    • Austria (AT)
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Germany (DE)
      Lacosamid hameln 10 mg/ml Infusionslösung
许可日期2023/01/05
最近更新日期2024/05/03
药物ATC编码
    • N03AX18 lacosamide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase